Johnson Matthey PLC (JMAT)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 2,434.00 |
|---|---|
| 52-week range | 1,731.83 – 2,534.00 |
| Return, 1 month / 3 months | +3.8% / +15.2% |
| Return, 1 year / 3 years | +5.4% / +69.9% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -25.1% |
| Average daily value traded | 1,047.99M GBX |
| Dividend yield | 17.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Johnson Matthey is a speciality chemicals company based in the United Kingdom. It makes catalysts and emission-control systems for cars, trucks and other vehicles, and supplies catalyst and process technologies to the chemicals, refining and pharmaceutical industries. It also produces materials for fuel cells and other clean-energy applications. Its customers are mainly manufacturers and industrial firms that need catalysts and advanced materials for their own production processes.
Johnson Matthey PLC trades under the code JMAT on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Johnson Matthey PLC (JMAT) trades on the London Exchange in UK. It last closed at GBX 2,434.00 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 377 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.4% and over the last three months it rose 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.7% | ||
| From 52-week high | -3.5% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.2% | ||
| 6-month return | 8.8% | ||
| 12-month return, skipping the last month | 1.6% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.1% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 1,047.99M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 92 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 17.8% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | +3.8% |
| 3 months | +15.2% |
| 6 months | +8.8% |
| 1 year | +5.4% |
| 3 years | +69.9% |
| 5 years | −0.4% |
Signals
| 50-day / 200-day average | 2,354.04 / 2,302.14 |
|---|---|
| Golden / death cross (60 days) | Golden, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 62.62 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Aug 2026 | GBP 3.5738 |
| 4 Jun 2026 | GBP 0.5500 |
| 27 Nov 2025 | GBP 0.2200 |
| 5 Jun 2025 | GBP 0.5500 |
| 5 Dec 2024 | GBP 0.2200 |
| 6 Jun 2024 | GBP 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.